Icon

AMBISOME (nda050740)- (50MG/VIAL)

AMPHOTERICIN B ASTELLAS
50MG/VIAL
No No
2016-Oct-12 Expired
None None
None No
AmBisome is indicated for the following: • Empirical therapy for presumed fungal infection in febrile, neutropenic patients. • Treatment of Cryptococcal Meningitis in HIV-infected patients . • Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate. • Treatment of visceral leishmaniasis. In immunocompromised patients with visceral leishmaniasis treated with AmBisome, relapse rates were high following initial clearance of parasites
2 0 2
Total Other Developers 28
Drugs with Suitability No
50MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** *** ************** ******** ******* *********** ****** **. ** *** ** - ******* :- ***** **** - *****, ***** **********, ******* ******, ***** (***) ***
****** ***** ****** *** ******** ******* ******* ****** ******* *********** **. * ******** **** ****, **** ********, ******* ****, *****, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.